Global Erythropoietin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Publisher Name :
Date: 19-Jul-2021
No. of pages: 119
Inquire Before Buying

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

Market Analysis and Insights: Global Erythropoietin Market

In 2020, the global Erythropoietin market size was US$ 8657 million and it is expected to reach US$ 12840 million by the end of 2027, with a CAGR of 5.8% during 2021-2027.

Global Erythropoietin Scope and Market Size

Erythropoietin market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Erythropoietin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Erythropoietin market is segmented into

- Epoetin-alfa

- Epoetin-beta

- Darbepoetin-alfa

- Others

Segment by Application, the Erythropoietin market is segmented into

- Anemia

- Kidney Disorders

- Others

Regional and Country-level Analysis:

- North America

- - United States

- - Canada

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Competitive Landscape and Erythropoietin Market Share Analysis

Erythropoietin market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Erythropoietin product introduction, recent developments, Erythropoietin sales by region, type, application and by sales channel.

The major companies include:

- Amgen

- Johnson & Johnson

- Roche

- Galenica

- Emcure

- Kyowa Hakko Kirin

- 3SBio

- Biocon

- LG Life Sciences

Global Erythropoietin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Erythropoietin Product Introduction
1.2 Market by Type
1.2.1 Global Erythropoietin Market Size Growth Rate by Type
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Market by Application
1.3.1 Global Erythropoietin Market Size Growth Rate by Application
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Erythropoietin Market Size Estimates and Forecasts
2.1.1 Global Erythropoietin Revenue 2016-2027
2.1.2 Global Erythropoietin Sales 2016-2027
2.2 Erythropoietin Market Size by Region: 2021 Versus 2027
2.3 Erythropoietin Sales by Region (2016-2027)
2.3.1 Global Erythropoietin Sales by Region: 2016-2021
2.3.2 Global Erythropoietin Sales Forecast by Region (2022-2027)
2.3.3 Global Erythropoietin Sales Market Share by Region (2016-2027)
2.4 Erythropoietin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Erythropoietin Revenue by Region: 2016-2021
2.4.2 Global Erythropoietin Revenue Forecast by Region (2022-2027)
2.4.3 Global Erythropoietin Revenue Market Share by Region (2016-2027)
3 Global Erythropoietin by Manufacturers
3.1 Global Top Erythropoietin Manufacturers by Sales
3.1.1 Global Erythropoietin Sales by Manufacturer (2016-2021)
3.1.2 Global Erythropoietin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Erythropoietin Manufacturers by Revenue
3.2.1 Global Erythropoietin Revenue by Manufacturer (2016-2021)
3.2.2 Global Erythropoietin Revenue Share by Manufacturer (2016-2021)
3.3 Global Erythropoietin Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Erythropoietin Manufacturers Covered: Ranking by Revenue
3.4.2 Global Erythropoietin Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Erythropoietin Manufacturing Base Distribution, Product Type
3.5.1 Erythropoietin Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Erythropoietin Product Type
3.5.3 Date of International Manufacturers Enter into Erythropoietin Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Amgen
4.1.1 Amgen Corporation Information
4.1.2 Amgen Description, Business Overview
4.1.3 Amgen Erythropoietin Products Offered
4.1.4 Amgen Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Amgen Erythropoietin Revenue by Product
4.1.6 Amgen Erythropoietin Revenue by Application
4.1.7 Amgen Erythropoietin Revenue by Geographic Area
4.1.8 Amgen Erythropoietin Revenue by Sales Channel
4.1.9 Amgen Recent Development
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Corporation Information
4.2.2 Johnson & Johnson Description, Business Overview
4.2.3 Johnson & Johnson Erythropoietin Products Offered
4.2.4 Johnson & Johnson Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Johnson & Johnson Erythropoietin Revenue by Product
4.2.6 Johnson & Johnson Erythropoietin Revenue by Application
4.2.7 Johnson & Johnson Erythropoietin Revenue by Geographic Area
4.2.8 Johnson & Johnson Erythropoietin Revenue by Sales Channel
4.2.9 Johnson & Johnson Recent Development
4.3 Roche
4.3.1 Roche Corporation Information
4.3.2 Roche Description, Business Overview
4.3.3 Roche Erythropoietin Products Offered
4.3.4 Roche Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Roche Erythropoietin Revenue by Product
4.3.6 Roche Erythropoietin Revenue by Application
4.3.7 Roche Erythropoietin Revenue by Geographic Area
4.3.8 Roche Erythropoietin Revenue by Sales Channel
4.3.9 Roche Recent Development
4.4 Galenica
4.4.1 Galenica Corporation Information
4.4.2 Galenica Description, Business Overview
4.4.3 Galenica Erythropoietin Products Offered
4.4.4 Galenica Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Galenica Erythropoietin Revenue by Product
4.4.6 Galenica Erythropoietin Revenue by Application
4.4.7 Galenica Erythropoietin Revenue by Geographic Area
4.4.8 Galenica Erythropoietin Revenue by Sales Channel
4.4.9 Galenica Recent Development
4.5 Emcure
4.5.1 Emcure Corporation Information
4.5.2 Emcure Description, Business Overview
4.5.3 Emcure Erythropoietin Products Offered
4.5.4 Emcure Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Emcure Erythropoietin Revenue by Product
4.5.6 Emcure Erythropoietin Revenue by Application
4.5.7 Emcure Erythropoietin Revenue by Geographic Area
4.5.8 Emcure Erythropoietin Revenue by Sales Channel
4.5.9 Emcure Recent Development
4.6 Kyowa Hakko Kirin
4.6.1 Kyowa Hakko Kirin Corporation Information
4.6.2 Kyowa Hakko Kirin Description, Business Overview
4.6.3 Kyowa Hakko Kirin Erythropoietin Products Offered
4.6.4 Kyowa Hakko Kirin Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Kyowa Hakko Kirin Erythropoietin Revenue by Product
4.6.6 Kyowa Hakko Kirin Erythropoietin Revenue by Application
4.6.7 Kyowa Hakko Kirin Erythropoietin Revenue by Geographic Area
4.6.8 Kyowa Hakko Kirin Recent Development
4.7 3SBio
4.7.1 3SBio Corporation Information
4.7.2 3SBio Description, Business Overview
4.7.3 3SBio Erythropoietin Products Offered
4.7.4 3SBio Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.7.5 3SBio Erythropoietin Revenue by Product
4.7.6 3SBio Erythropoietin Revenue by Application
4.7.7 3SBio Erythropoietin Revenue by Geographic Area
4.7.8 3SBio Recent Development
4.8 Biocon
4.8.1 Biocon Corporation Information
4.8.2 Biocon Description, Business Overview
4.8.3 Biocon Erythropoietin Products Offered
4.8.4 Biocon Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Biocon Erythropoietin Revenue by Product
4.8.6 Biocon Erythropoietin Revenue by Application
4.8.7 Biocon Erythropoietin Revenue by Geographic Area
4.8.8 Biocon Recent Development
4.9 LG Life Sciences
4.9.1 LG Life Sciences Corporation Information
4.9.2 LG Life Sciences Description, Business Overview
4.9.3 LG Life Sciences Erythropoietin Products Offered
4.9.4 LG Life Sciences Erythropoietin Sales, Revenue and Gross Margin (2016-2021)
4.9.5 LG Life Sciences Erythropoietin Revenue by Product
4.9.6 LG Life Sciences Erythropoietin Revenue by Application
4.9.7 LG Life Sciences Erythropoietin Revenue by Geographic Area
4.9.8 LG Life Sciences Recent Development
5 Breakdown Data by Type
5.1 Global Erythropoietin Sales by Type (2016-2027)
5.1.1 Global Erythropoietin Sales by Type (2016-2021)
5.1.2 Global Erythropoietin Sales Forecast by Type (2022-2027)
5.1.3 Global Erythropoietin Sales Market Share by Type (2016-2027)
5.2 Global Erythropoietin Revenue Forecast by Type (2016-2027)
5.2.1 Global Erythropoietin Revenue by Type (2016-2021)
5.2.2 Global Erythropoietin Revenue Forecast by Type (2022-2027)
5.2.3 Global Erythropoietin Revenue Market Share by Type (2016-2027)
5.3 Erythropoietin Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Erythropoietin Sales by Application (2016-2027)
6.1.1 Global Erythropoietin Sales by Application (2016-2021)
6.1.2 Global Erythropoietin Sales Forecast by Application (2022-2027)
6.1.3 Global Erythropoietin Sales Market Share by Application (2016-2027)
6.2 Global Erythropoietin Revenue Forecast by Application (2016-2027)
6.2.1 Global Erythropoietin Revenue by Application (2016-2021)
6.2.2 Global Erythropoietin Revenue Forecast by Application (2022-2027)
6.2.3 Global Erythropoietin Revenue Market Share by Application (2016-2027)
6.3 Erythropoietin Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Erythropoietin Market Size YoY Growth 2016-2027
7.2 North America Erythropoietin Market Facts & Figures by Country
7.2.1 North America Erythropoietin Sales by Country (2016-2027)
7.2.2 North America Erythropoietin Revenue by Country (2016-2027)
7.3 North America Erythropoietin Sales by Type
7.4 North America Erythropoietin Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Erythropoietin Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Erythropoietin Market Facts & Figures by Region
8.2.1 Asia-Pacific Erythropoietin Sales by Region (2016-2027)
8.2.2 Asia-Pacific Erythropoietin Revenue by Region (2016-2027)
8.3 Asia-Pacific Erythropoietin Sales by Type
8.4 Asia-Pacific Erythropoietin Sales by Application
9 Europe
9.1 Europe Erythropoietin Market Size YoY Growth 2016-2027
9.2 Europe Erythropoietin Market Facts & Figures by Country
9.2.1 Europe Erythropoietin Sales by Country (2016-2027)
9.2.2 Europe Erythropoietin Revenue by Country (2016-2027)
9.3 Europe Erythropoietin Sales by Type
9.4 Europe Erythropoietin Sales by Application
10 Latin America
10.1 Latin America Erythropoietin Market Size YoY Growth 2016-2027
10.2 Latin America Erythropoietin Market Facts & Figures by Country
10.2.1 Latin America Erythropoietin Sales by Country (2016-2027)
10.2.2 Latin America Erythropoietin Revenue by Country (2016-2027)
10.3 Latin America Erythropoietin Sales by Type
10.4 Latin America Erythropoietin Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Erythropoietin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Erythropoietin Market Facts & Figures by Country
11.2.1 Middle East and Africa Erythropoietin Sales by Country (2016-2027)
11.2.2 Middle East and Africa Erythropoietin Revenue by Country (2016-2027)
11.3 Middle East and Africa Erythropoietin Sales by Type
11.4 Middle East and Africa Erythropoietin Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Erythropoietin Supply Chain Analysis
12.2 Erythropoietin Key Raw Materials and Upstream Suppliers
12.3 Erythropoietin Clients Analysis
12.4 Erythropoietin Sales Channel and Sales Model Analysis
12.4.1 Erythropoietin Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Erythropoietin Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Erythropoietin Distributors
13 Market Dynamics
13.1 Erythropoietin Market Drivers
13.2 Erythropoietin Market Opportunities
13.3 Erythropoietin Market Challenges
13.4 Erythropoietin Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Erythropoietin Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Epoetin-alfa
Table 3. Major Manufacturers of Epoetin-beta
Table 4. Major Manufacturers of Darbepoetin-alfa
Table 5. Major Manufacturers of Others
Table 6. Global Erythropoietin Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 7. Global Erythropoietin Market Size by Region (US$ Million): 2021 VS 2027
Table 8. Global Erythropoietin Sales by Region (2016-2021) & (M Units)
Table 9. Global Erythropoietin Sales Forecast by Region (2022-2027) & (M Units)
Table 10. Global Erythropoietin Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Erythropoietin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Erythropoietin Sales by Manufacturer (2016-2021) & (M Units)
Table 13. Global Erythropoietin Sales Share by Manufacturer (2016-2021)
Table 14. Erythropoietin Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 15. Erythropoietin Revenue Share by Manufacturer (2016-2021)
Table 16. Key Manufacturers Erythropoietin Price (2016-2021) & (US$/Unit)
Table 17. Ranking of Global Top Erythropoietin Manufacturers by Revenue (US$ Million) in 2020
Table 18. Global Erythropoietin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Erythropoietin by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erythropoietin as of 2020)
Table 20. Erythropoietin Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Erythropoietin Product Type
Table 22. Date of International Manufacturers Enter into Erythropoietin Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Amgen Corporation Information
Table 25. Amgen Description and Business Overview
Table 26. Amgen Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 27. Amgen Erythropoietin Product
Table 28. Amgen Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 29. Amgen Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 30. Amgen Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 31. Amgen Erythropoietin Revenue (US$ Million) and Market Share by Sales Channel
Table 32. Amgen Recent Development
Table 33. Johnson & Johnson Corporation Information
Table 34. Johnson & Johnson Description and Business Overview
Table 35. Johnson & Johnson Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 36. Johnson & Johnson Erythropoietin Product
Table 37. Johnson & Johnson Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 38. Johnson & Johnson Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 39. Johnson & Johnson Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Johnson & Johnson Erythropoietin Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Johnson & Johnson Recent Development
Table 42. Roche Corporation Information
Table 43. Roche Description and Business Overview
Table 44. Roche Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 45. Roche Erythropoietin Product
Table 46. Roche Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 47. Roche Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 48. Roche Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 49. Roche Erythropoietin Revenue (US$ Million) and Market Share by Sales Channel
Table 50. Roche Recent Development
Table 51. Galenica Corporation Information
Table 52. Galenica Description and Business Overview
Table 53. Galenica Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 54. Galenica Erythropoietin Product
Table 55. Galenica Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 56. Galenica Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 57. Galenica Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Galenica Erythropoietin Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Galenica Recent Development
Table 60. Emcure Corporation Information
Table 61. Emcure Description and Business Overview
Table 62. Emcure Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 63. Emcure Erythropoietin Product
Table 64. Emcure Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 65. Emcure Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 66. Emcure Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 67. Emcure Erythropoietin Revenue (US$ Million) and Market Share by Sales Channel
Table 68. Emcure Recent Development
Table 69. Kyowa Hakko Kirin Corporation Information
Table 70. Kyowa Hakko Kirin Description and Business Overview
Table 71. Kyowa Hakko Kirin Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 72. Kyowa Hakko Kirin Erythropoietin Product
Table 73. Kyowa Hakko Kirin Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 74. Kyowa Hakko Kirin Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 75. Kyowa Hakko Kirin Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 76. Kyowa Hakko Kirin Recent Development
Table 77. 3SBio Corporation Information
Table 78. 3SBio Description and Business Overview
Table 79. 3SBio Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 80. 3SBio Erythropoietin Product
Table 81. 3SBio Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 82. 3SBio Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 83. 3SBio Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 84. 3SBio Recent Development
Table 85. Biocon Corporation Information
Table 86. Biocon Description and Business Overview
Table 87. Biocon Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 88. Biocon Erythropoietin Product
Table 89. Biocon Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 90. Biocon Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 91. Biocon Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 92. Biocon Recent Development
Table 93. LG Life Sciences Corporation Information
Table 94. LG Life Sciences Description and Business Overview
Table 95. LG Life Sciences Erythropoietin Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. LG Life Sciences Erythropoietin Product
Table 97. LG Life Sciences Erythropoietin Revenue (US$ Million) and Market Share by Product
Table 98. LG Life Sciences Erythropoietin Revenue (US$ Million) and Market Share by Application
Table 99. LG Life Sciences Erythropoietin Revenue (US$ Million) and Market Share by Geographic Area
Table 100. LG Life Sciences Recent Development
Table 101. Global Erythropoietin Sales by Type (2016-2021) & (M Units)
Table 102. Global Erythropoietin Sales Forecast by Type (2022-2027) & (M Units)
Table 103. Global Erythropoietin Revenue by Type (2016-2021) & (US$ Million)
Table 104. Global Erythropoietin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 105. Global Erythropoietin Sales by Application (2016-2021) & (M Units)
Table 106. Global Erythropoietin Sales Forecast by Application (2022-2027) & (M Units)
Table 107. Global Erythropoietin Revenue by Application (2016-2021) & (US$ Million)
Table 108. Global Erythropoietin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 109. North America Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 110. North America Erythropoietin Sales by Country (2022-2027) & (M Units)
Table 111. North America Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 112. North America Erythropoietin Revenue by Country (2022-2027) & (US$ Million)
Table 113. North America Erythropoietin Sales by Type (2016-2021) & (M Units)
Table 114. North America Erythropoietin Sales by Application (2016-2021) & (M Units)
Table 115. Asia-Pacific Erythropoietin Sales by Region (2016-2021) & (M Units)
Table 116. Asia-Pacific Erythropoietin Sales by Region (2022-2027) & (M Units)
Table 117. Asia-Pacific Erythropoietin Revenue by Region (2016-2027) & (US$ Million)
Table 118. Asia-Pacific Erythropoietin Revenue by Region (2022-2027) & (US$ Million)
Table 119. Asia-Pacific Erythropoietin Sales by Type (2016-2021) & (M Units)
Table 120. Asia-Pacific Erythropoietin Sales by Application (2016-2021) & (M Units)
Table 121. Europe Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 122. Europe Erythropoietin Sales by Country (2022-2027) & (M Units)
Table 123. Europe Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 124. Europe Erythropoietin Revenue by Country (2022-2027) & (US$ Million)
Table 125. Europe Erythropoietin Sales by Type (2016-2021) & (M Units)
Table 126. Europe Erythropoietin Sales by Application (2016-2021) & (M Units)
Table 127. Latin America Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 128. Latin America Erythropoietin Sales by Country (2022-2027) & (M Units)
Table 129. Latin America Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 130. Latin America Erythropoietin Revenue by Country (2022-2027) & (US$ Million)
Table 131. Latin America Erythropoietin Sales by Type (2016-2021) & (M Units)
Table 132. Latin America Erythropoietin Sales by Application (2016-2021) & (M Units)
Table 133. Middle East and Africa Erythropoietin Sales by Country (2016-2021) & (M Units)
Table 134. Middle East and Africa Erythropoietin Sales by Country (2022-2027) & (M Units)
Table 135. Middle East and Africa Erythropoietin Revenue by Country (2016-2021) & (US$ Million)
Table 136. Middle East and Africa Erythropoietin Revenue by Country (2022-2027) & (US$ Million)
Table 137. Middle East and Africa Erythropoietin Sales by Type (2016-2021) & (M Units)
Table 138. Middle East and Africa Erythropoietin Sales by Application (2016-2021) & (M Units)
Table 139. Erythropoietin Key Raw Materials, Industry Status and Trend
Table 140. Erythropoietin Key Raw Materials and Upstream Suppliers
Table 141. Erythropoietin Clients Status and Trend
Table 142. Erythropoietin Typical Clients
Table 143. Erythropoietin Distributors
Table 144. Key Drivers: Impact Analysis (2022-2027)
Table 145. Erythropoietin Market Drivers
Table 146. Erythropoietin Market Opportunities
Table 147. Erythropoietin Market Challenges
Table 148. Erythropoietin Market Restraints
Table 149. Erythropoietin Porter's Five Forces Analysis
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Erythropoietin Product Picture
Figure 2. Global Erythropoietin Sales Market Share by Type in 2021 & 2027
Figure 3. Epoetin-alfa Product Picture
Figure 4. Epoetin-beta Product Picture
Figure 5. Darbepoetin-alfa Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erythropoietin Sales Market Share by Application in 2021 & 2027
Figure 8. Anemia Examples
Figure 9. Kidney Disorders Examples
Figure 10. Others Examples
Figure 11. Erythropoietin Report Years Considered
Figure 12. Global Erythropoietin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Erythropoietin Market Size 2016-2027 (US$ Million)
Figure 14. Global Erythropoietin Sales 2016-2027 (K Units)
Figure 15. Global Erythropoietin Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Erythropoietin Sales Market Share Forecast by Region (2016-2027)
Figure 17. Global Erythropoietin Revenue Market Share by Region (2016-2027)
Figure 18. Global Erythropoietin Sales Share by Manufacturer in 2020
Figure 19. Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Erythropoietin Sales Market Share Forecast by Type (2016-2027)
Figure 21. Global Erythropoietin Revenue Market Share Forecast by Type (2016-2027)
Figure 22. Erythropoietin Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 23. Global Erythropoietin Sales Market Share Forecast by Application (2016-2027)
Figure 24. Global Erythropoietin Revenue Market Share Forecast by Application (2016-2027)
Figure 25. Erythropoietin Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 26. North America Erythropoietin Revenue 2016-2027 (US$ Million)
Figure 27. North America Erythropoietin Sales Market Share by Type (2016-2021)
Figure 28. North America Erythropoietin Sales Market Share by Application (2016-2021)
Figure 29. Asia-Pacific Erythropoietin Revenue 2016-2027 (US$ Million)
Figure 30. Asia-Pacific Erythropoietin Sales Market Share by Region (2016-2027)
Figure 31. Asia-Pacific Erythropoietin Revenue Market Share by Region (2016-2027)
Figure 32. Asia-Pacific Erythropoietin Sales Market Share by Type (2016-2021)
Figure 33. Asia-Pacific Erythropoietin Sales Market Share by Application (2016-2021)
Figure 34. Europe Erythropoietin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. Europe Erythropoietin Sales Market Share by Country (2016-2027)
Figure 36. Europe Erythropoietin Revenue Market Share by Country (2016-2027)
Figure 37. Europe Erythropoietin Sales Market Share by Type (2016-2021)
Figure 38. Europe Erythropoietin Sales Market Share by Application (2016-2021)
Figure 39. Latin America Erythropoietin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 40. Latin America Erythropoietin Sales Market Share by Country (2016-2027)
Figure 41. Latin America Erythropoietin Revenue Market Share by Country (2016-2021)
Figure 42. Latin America Erythropoietin Sales Market Share by Type (2016-2021)
Figure 43. Latin America Erythropoietin Sales Market Share by Application (2016-2021)
Figure 44. Middle East and Africa Erythropoietin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 45. Middle East and Africa Erythropoietin Sales Market Share by Country (2016-2027)
Figure 46. Middle East and Africa Erythropoietin Revenue Market Share by Country (2016-2027)
Figure 47. Middle East and Africa Erythropoietin Sales Market Share by Type (2016-2021)
Figure 48. Middle East and Africa Erythropoietin Sales Market Share by Application (2016-2021)
Figure 49. Erythropoietin Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Erythropoietin Raw Materials by Region in 2020
Figure 51. Erythropoietin Distribution Channels
Figure 52. Global Erythropoietin Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 53. Global Erythropoietin Percentage 2016-2027: Online Sales VS Offline Sales
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs